Intra-Cellular Therapies saw the highest growth of 499% in patent filings in January and 299% in grants in February in Q1 2024. Compared to Q4 2023, Q1 2024 saw an increase in patent filings by 499% and grants by 24%. GlobalData’s DataBook provides a comprehensive analysis of Intra-Cellular Therapies‘s patent filings and grants. Buy the databook here.

Smarter leaders trust GlobalData

Intra-Cellular Therapies has been focused on protecting inventions in United States(US) with 13 publications in Q1 2024

The United States(US) Patent Office dominates the patent filings and grants with nearly 57% filings and 10% grants. The United States(US), World Intellectual Property Organization(WIPO), Israel(IL), and Australia(AU) patent Office are among the top ten patent offices where Intra-Cellular Therapies is filings its patents. Among the top granted patent authorities, Intra-Cellular Therapies has 30% of its grants in Israel(IL), 30% in Canada(CA) and 10% in United States(US).

Gilead Sciences and F. Hoffmann-La Roche could be the strongest competitors for Intra-Cellular Therapies

In terms of grant share, Intra-Cellular Therapies stands first among its competitors followed by Gilead Sciences and F. Hoffmann-La Roche.

Patents related to addiction and rare diseases lead Intra-Cellular Therapies's portfolio

Intra-Cellular Therapies has the highest number of patents in addiction followed by, rare diseases and cell & gene therapy. For addiction, nearly 50% of patents were filed and 50% of patents were granted in Q1 2024.

Hashimoto thyroiditis related patents lead Intra-Cellular Therapies portfolio followed by psychosis, and schizophrenia

Intra-Cellular Therapies has highest number of patents in hashimoto thyroiditis followed by psychosis, schizophrenia, depression, and sleep disorders. For hashimoto thyroiditis, nearly 4% of patents were filed and 10% of patents were granted in Q1 2024.

For comprehensive analysis of Intra-Cellular Therapies's filings and grants, buy the databook here.

Data Insights


The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.


GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.

Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.